Mayo Clinic study: Antibody-rich plasma treatment reduced deaths for COVID-19 patients


Photo credits: nypost.com


Blood plasma transfusions with high concentrations of COVID-19 antibodies reduced deaths among some virus patients, according to a new study conducted by Mayo Clinic researchers, lending credibility to one of the few known treatments for the illness.


“Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of Covid-19,” the researchers concluded.


For the full story click here.

0 comments

© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.